Total Funding
25
42
Total FundingSeries C raised
Growth Score
1 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
66183
Focusing on major innovative vaccines with independent intellectual property rights.
- Zhang Jianhui: Chief Medical Officer
- Dr. Yong Liu: Founder, Chairman of the Board and General Manager
About the Company
Recbio, founded in 2012, is an innovative vaccine company based on independent research and development technology. It is dedicated to establishing a full value chain for innovative vaccines, including research and development, manufacturing, and commercialization. The company has always adhered to its mission of "creating first-class vaccines
and protecting human health". With a strong R&D engine comprised of novel adjuvants, protein engineering, immunological evaluation, and other core technology platforms, the company is strategically focusing on disease areas with high burdens such as cervical cancers.
